Composition

Composition comprising extracts of Abutilon fruticosum (wancad), Acacia nubica (gumar), Acacia bussei (galool) and Myrsine africana (qorsheen or qurjeen). Antiviral formulation and a viral prophylactic formulation comprising the composition and a method of producing a composition comprising: a) mixing extracts of wancad, gumar, galool and optionally qorsheen, b) adding the extracts to water, c) optionally adding Boswellia frereana (maydi) extract, d) boiling, e) removing the heat, f) filtering and g) sealing the mixture in a container are also included. The composition may comprise maydi extract. The wancad or gumar may be root powder, the galool may be bark powder, the maydi may be resin and the qorsheen may be fruit powder. The composition may be a liquid or tablet. The composition may comprise water. The liquid form may comprise 300-500 g maydi, 4-10 g wancad, 4-10 g gumar, 1-3 g galool, 1-3 g qorsheen and 750-1250 ml of liquid. The tablet may comprise 40-59% galool, 40-59% gumar, 0.5-3% wancad and 0.5-3% qorsheen. The composition may be nasal drops or sprays, mouth sprays or for gargling and may be effective against influenza, respiratory syncytial virus, human metapneumovirus, parainfluenza virus, coronaviruses and rhinoviruses.